Richard Harland

• 
  agwest.sk.ca/events/AnimalHealthandNutrition/animal-hea - [Cached Version]
  Published on: 2/6/2007    Last Visited: 3/11/2007  

  Dr. Richard Harland - Novartis - Animal Health
  ...
  Richard Harland

• 
  Board of Directors - [Cached Version]
  Published on: 12/23/2005    Last Visited: 12/23/2005  

  Richard HarlandPast PresidentNovartis Animal Health U.S. Inc.1447 - 149 StreetLarchwood, Iowa USA 51241Phone: 712-477-2811, ext. 352Fax: 712-477-2810

• 
  Dairybusiness.com - New Product Directory - [Cached Version]
  Published on: 7/29/2005    Last Visited: 8/6/2005  

  A recent expert roundtable discussion addressed disease syndromes caused by Clostridium perfringens Type A. Participating were doctors David Van Metre of Colorado State University, Mike Holland of North Valley Veterinary Clinic in Gooding, Idaho, and Jim Rhoades and Richard Harland of Novartis Animal Health US Inc.

• 
  Horse Racing and Breeding Information from The... - [Cached Version]
  Published on: 8/26/2003    Last Visited: 8/27/2003  

  Richard Harland, DVM, director of research and development for Novartis Animal Vaccines, said, "When it comes to caring for horses that have the West Nile virus, veterinarians' options have been limited.Novartis has responded to this urgent need by developing a product that works against the virus."
  
  According to Novartis, a study was performed at Cornell University that demonstrated the ability of the product to neutralize WNV."Based on the study, researchers concluded there is a reasonable expectation of efficacy when the West Nile Virus Antibody is administered to horses that have been exposed to the virus," a release from the company stated.
  
  "Field safety trials conducted to bring the product to market demonstrated West Nile Virus Antibody is safe when used according to label directions," said Harland.He also emphasized the importance of a routine vaccination schedule for horses and management steps to reduce mosquitoes in the stable area, thereby decreasing the chances of exposure.
  
  "If an owner observes any clinical signs -- such as ataxia, depression, weakness of limbs, partial paralysis, and muscle twitching -- they should contact their veterinarian immediately," Harland explained.

• 
  Illinois Farm Bureau - [Cached Version]
  Published on: 8/17/2004    Last Visited: 6/21/2005  

  "HBS strikes apparently healthy animals without much warning," says Richard Harland, DVM, director of research and development for Novartis Animal Health."It often begins with a sudden and sometimes massive hemorrhage into the small intestine, resulting in blood clots that obstruct the intestine.It has an estimated case fatality rate of 85 percent within the first 24 to 36 hours."
  
  According to the National Animal Health Monitoring System, the number of operations reporting an initial case of HBS has been increasing dramatically since 1996, which suggests that this is an emerging disease.
  
  "In addition, medical and surgical treatments often fail," Harland says."HBS prevention and management strategies are crucial."
  
  The new Clostridium Perfringens Type A Toxoid from Novartis is safe for pregnant or non-pregnant animals.
  
  "Field studies involving 867 dairy and beef cattle, both open and pregnant, of various ages and breeds demonstrated that the vaccine is safe when used according to label directions," Harland says.
  
  "It surpassed USDA standardized tests for conditional licensing," he adds.

• 
  Products - [Cached Version]
  Published on: 1/8/2005    Last Visited: 1/8/2005  

  According to Richard Harland, DVM, director of research and development for Novartis Animal Health, the product potentially can save the lives of horses who have contracted the virus and are exhibiting clinical signs of the disease.

• 
  Provided by - [Cached Version]
  Published on: 8/1/2003    Last Visited: 10/30/2003  

  Richard Harland, DVM, director of research and development for Novartis Animal Vaccines, said, "When it comes to caring for horses that have the West Nile virus, veterinarians' options have been limited.Novartis has responded to this urgent need by developing a product that works against the virus."
  
  According to Novartis, a study was performed at Cornell University that demonstrated the ability of the product to neutralize WNV."Based on the study, researchers concluded there is a reasonable expectation of efficacy when the West Nile Virus Antibody is administered to horses that have been exposed to the virus," a release from the company stated.
  
  "Field safety trials conducted to bring the product to market demonstrated West Nile Virus Antibody is safe when used according to label directions," said Harland.He also emphasized the importance of a routine vaccination schedule for horses and management steps to reduce mosquitoes in the stable area, thereby decreasing the chances of exposure.
  
  "If an owner observes any clinical signs-such as ataxia, depression, weakness of limbs, partial paralysis, and muscle twitching-they should contact their veterinarian immediately," Harland explained.

• 
  TheHorse.com: WNV Treatment Licensed - [Cached Version]
  Last Visited: 3/31/2004  

  "Field studies involving 106 horses demonstrated the product is safe when administered according to label directions," said Richard Harland, DVM, director of research and development for Novartis Animal Vaccines.He suggested premedicating the horses with flunixin meglumine (Banamine) to reduce the risk of anaphylactic reactions (rapidly developing, exaggerated, and sometimes life-threatening allergic reactions).

• 
  TheHorse.com: Your Online Guide to Equine Health Care - [Cached Version]
  Published on: 9/10/2003    Last Visited: 9/12/2003  

  "Field studies involving 106 horses demonstrated the product is safe when administered according to label directions," said Richard Harland, DVM, director of research and development for Novartis Animal Vaccines.He suggested premedicating the horses with flunixin meglumine (Banamine) to reduce the risk of anaphylactic reactions (rapidly developing, exaggerated, and sometimes life-threatening allergic reactions).

• 
  TheHorse.com: Your Online Guide to Equine Health Care - [Cached Version]
  Published on: 9/5/2003    Last Visited: 9/17/2003  

  Richard Harland, DVM, director of research and development for Novartis Animal Vaccines, said, "When it comes to caring for horses that have the West Nile virus, veterinarians' options have been limited.
  ...
  "Field studies involving 106 horses demonstrated the product is safe when administered according to label directions," said Harland in a company Q&A on the product.He suggested premedicating the horses with flunixin meglumine (Banamine) to reduce the risk of anaphylactic reactions (rapidly developing, exaggerated, sometimes life-threatening allergic reactions), which are not likely but might occur.

Page:  1 2